Sun Pharma Advanced Research Co (NSE:SPARC) Change In Receivables : ₹0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Change In Receivables?

Sun Pharma Advanced Research Co's change in receivables for the quarter that ended in Sep. 2024 was ₹0.0 Mil. It means Sun Pharma Advanced Research Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Sun Pharma Advanced Research Co's change in receivables for the fiscal year that ended in Mar. 2024 was ₹152.1 Mil. It means Sun Pharma Advanced Research Co's Accounts Receivable declined by ₹152.1 Mil from Mar. 2023 to Mar. 2024 .

Sun Pharma Advanced Research Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹0.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sun Pharma Advanced Research Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sun Pharma Advanced Research Co's liquidation value for the three months ended in Sep. 2024 was ₹0.0 Mil.

Sun Pharma Advanced Research Co Change In Receivables Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Change In Receivables Chart

Sun Pharma Advanced Research Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-58.31

-15.44

-101.46

-50.06

152.14

Sun Pharma Advanced Research Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Sun Pharma Advanced Research Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

Sun Pharma Advanced Research Co (NSE:SPARC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sun Pharma Advanced Research Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	128.6	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Sun Pharma Advanced Research Co's accounts receivable are only considered to be worth 75% of book value:

Sun Pharma Advanced Research Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0.0

Sun Pharma Advanced Research Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Change In Receivables

Traded in Other Exchanges

532872:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines